Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum CgA Levels in Pancreatic Endocrine Tumors
NCT02759718Phase 4Unknown
- Sponsor
- Asan Medical Center
- Start
- Jun 2012
- Primary completion
- May 2017
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Asan Medical Center. Primary endpoint: Diagnostic accuracy of the CgA in the patient with PNET, change from preoperative levels of CgA at 3 months. Status: unknown.
Beyond the preview
Go deeper on NCT02759718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02759718.